Pricing Deregulation: 340B Pharmacy Policy, Medicaid Payment Rules May Be Withdrawn
Trump administration's drug pricing action plan considers withdrawing guidance and whole or parts of rules that biopharma has opposed.
Trump administration's drug pricing action plan considers withdrawing guidance and whole or parts of rules that biopharma has opposed.